Drugplain

Obagi-C C-Rx System Normal-Dry Skin Intervention

HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE · KIT · Obagi Cosmeceuticals LLC

No Recall History
Plain English

Obagi-C C-Rx System Normal-Dry Skin Intervention is a kit containing hydroquinone, homosalate, octisalate, zinc oxide. Manufactured by Obagi Cosmeceuticals LLC.

Key Facts

Brand Name
Obagi-C C-Rx System Normal-Dry Skin Intervention
Generic Name
HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE
NDC Code (Product)
62032-916
Manufacturer
Obagi Cosmeceuticals LLC
Dosage Form
KIT
Marketing Status
Marketing Start
12/02/2019

Recall History

No Recall History

Frequently Asked Questions

What is Obagi-C C-Rx System Normal-Dry Skin Intervention used for?

Obagi-C C-Rx System Normal-Dry Skin Intervention contains HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE. It is a kit taken as directed. Consult your doctor for specific uses.

Is Obagi-C C-Rx System Normal-Dry Skin Intervention a controlled substance?

Obagi-C C-Rx System Normal-Dry Skin Intervention is not classified as a controlled substance by the DEA.

What is the generic name for Obagi-C C-Rx System Normal-Dry Skin Intervention?

The generic name for Obagi-C C-Rx System Normal-Dry Skin Intervention is HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE. There are 5 other brand versions of HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE.

What is the NDC code for Obagi-C C-Rx System Normal-Dry Skin Intervention ?

The NDC (National Drug Code) for Obagi-C C-Rx System Normal-Dry Skin Intervention is 62032-916, listed by Obagi Cosmeceuticals LLC.

Product NDC

62032-916

Package NDC

62032-916-01

Other Hydroquinone, Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)